V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013336 | 160012200 | 1.72 | 59.9 | null | 2018-07-17 | 2018-08-02 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100640012 |
| 160013338 | 160012201 | 1.75 | 86.55 | Palliative (P) | 2022-04-19 | 2022-04-20 | Doxorubicin 75mg/m2 | 02 | N | TRIAL UNSPECIFIED | 101018061 |
| 160013339 | 160012202 | 1.77 | 92 | null | 2016-02-05 | 2016-02-05 | DOXORUBICIN | null | null | TRIAL UNSPECIFIED | 101060229 |
| 160013340 | 160012203 | 1.55 | 64 | null | 2020-08-06 | 2020-08-15 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100897656 |
| 160013342 | 160012204 | 1.63 | 80.6 | Palliative (P) | 2021-06-11 | 2021-06-24 | Vinorelbine (oral) | 02 | N | VINORELBINE | 101817793 |
| 160013344 | 160012205 | 1.79 | 77.8 | Palliative (P) | 2019-03-16 | 2019-03-28 | DOXORUBICIN | N | N | TRIAL UNSPECIFIED | 101474184 |
| 160013345 | 160012206 | 1.73 | 98 | Palliative (P) | 2020-08-31 | 2020-09-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100698434 |
| 160013348 | 160012207 | 1.67 | 57.3 | Palliative (P) | 2019-05-04 | 2019-05-04 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 100375740 |
| 160013353 | 160012208 | 1.81 | 97.5 | Palliative (P) | 2018-03-07 | 2018-03-10 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100224197 |
| 160013357 | 160012209 | 1.64 | 62.15 | Palliative (P) | 2018-04-16 | 2018-04-23 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101067983 |
| 160013359 | 160012210 | 1.81 | 56.6 | Palliative (P) | 2020-08-31 | 2020-08-31 | DOXORUBICIN | 02 | N | NIVOLUMAB | 101005052 |
| 160013364 | 160012211 | 1.66 | 77.8 | null | 2021-03-26 | 2021-04-09 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 101684272 |
| 160013365 | 160012212 | 0 | 78.4 | Palliative (P) | null | 2018-06-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100523332 |
| 160013371 | 160012213 | 1.66 | 81.2 | Palliative (P) | 2019-06-13 | 2019-06-14 | VINORELBINE | N | N | VINORELBINE | 101050318 |
| 160013372 | 160012214 | 1.75 | 82 | null | 2021-01-21 | 2021-02-17 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101726089 |
| 160013373 | 160012215 | 1.56 | 67.7 | Palliative (P) | 2022-04-25 | 2022-05-06 | Trabectedin | N | N | TRABECTEDIN | 101561088 |
| 160013374 | 160012216 | 1.77 | 64.1 | null | 2016-04-18 | 2016-04-19 | Doxorubicin 75mg/m2 | 02 | null | NIVOLUMAB | 100159492 |
| 160013375 | 160012217 | 1.9 | 104 | Palliative (P) | 2017-07-30 | 2017-08-04 | DOXORUBICIN | 02 | N | NIVOLUMAB | 101181422 |
| 160013379 | 160012218 | 1.75 | 83 | Palliative (P) | null | 2020-08-10 | Trabectedin | 02 | N | TRABECTEDIN | 100401618 |
| 160013381 | 160012219 | 1.61 | 68.8 | null | 2020-02-22 | 2020-03-08 | Trabectedin | 02 | null | TRABECTEDIN | 101201492 |
| 160013384 | 160012220 | 1.74 | 52.8 | null | 2019-02-07 | 2019-02-13 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100590311 |
| 160013385 | 160012221 | 1.82 | 53.8 | null | 2019-08-15 | 2019-08-15 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101523717 |
| 160013389 | 160012222 | 1.74 | 115.6 | Curative (C) | 2016-09-17 | 2016-09-24 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101833545 |
| 160013391 | 160012223 | 1.79 | 74.65 | Palliative (P) | 2017-07-06 | 2017-07-20 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100657827 |
| 160013393 | 160012224 | 1.73 | 90.7 | Palliative (P) | 2020-08-08 | 2020-08-08 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101436262 |
| 160013394 | 160012225 | 1.74 | 54.3 | null | 2017-10-06 | 2017-10-06 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100193155 |
| 160013397 | 160012226 | 1.77 | 83.5 | null | 2018-11-29 | 2018-11-29 | Trabectedin | N | null | DOXORUBICIN | 101442422 |
| 160013402 | 160012227 | 1.6 | 60.5 | Palliative (P) | 2016-09-21 | 2016-09-29 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101472333 |
| 160013407 | 160012228 | 1.72 | 97.5 | null | 2019-03-28 | 2019-04-13 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101212077 |
| 160013408 | 160012229 | 1.85 | 38.35 | Palliative (P) | 2020-08-26 | 2020-09-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101393182 |
| 160013409 | 160012230 | 1.74 | 70.4 | Palliative (P) | 2018-01-09 | 2018-01-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100716809 |
| 160013411 | 160012231 | 1.56 | 83.3 | Palliative (P) | 2020-08-10 | 2020-08-13 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101717828 |
| 160013414 | 160012232 | 1.72 | 61 | Palliative (P) | 2018-03-21 | 2018-07-06 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100000701 |
| 160013415 | 160012233 | 1.72 | 70.8 | null | 2019-12-19 | 2019-12-27 | Vinorelbine (oral) | 2 | null | VINORELBINE | 101401710 |
| 160013416 | 160012234 | 1.63 | 65 | null | 2018-12-29 | 2019-01-02 | Trabectedin | null | null | TRABECTEDIN | 101195834 |
| 160013420 | 160012235 | 1.07 | 92.2 | Palliative (P) | 2017-05-12 | 2017-05-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100363637 |
| 160013422 | 160012236 | 1.49 | 62.6 | Palliative (P) | 2020-01-12 | 2020-01-20 | Vinorelbine (oral) | 02 | null | VINORELBINE | 100232852 |
| 160013426 | 160012237 | 1.72 | 93 | Palliative (P) | 2018-01-08 | 2018-01-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101235870 |
| 160013427 | 160012238 | 1.54 | 75 | Palliative (P) | 2018-09-28 | 2019-02-06 | Docetaxel + Gemcitabine with GCSF | 02 | N | DOCETAXEL + GEMCITABINE | 100153219 |
| 160013433 | 160012239 | 1.83 | 74 | null | 2018-10-20 | 2018-11-09 | Bevacizumab 7.5mg/kg | 02 | null | LIPOSOMAL DOXORUBICIN | 100346681 |
| 160013434 | 160012240 | 1.59 | 106 | Palliative (P) | 2021-06-20 | 2021-09-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100418340 |
| 160013440 | 160012241 | 1.8 | 106 | Palliative (P) | 2017-09-30 | 2018-02-10 | Bevacizumab | 02 | null | DOXORUBICIN + OLARATUMAB | 101808874 |
| 160013444 | 160012242 | 1.71 | 80.5 | Palliative (P) | 2020-01-13 | 2020-01-13 | Bevacizumab 7.5mg/kg | 2 | N | DOXORUBICIN + OLARATUMAB | 101333690 |
| 160013452 | 160012243 | 1.85 | 73.3 | Palliative (P) | 2018-02-25 | 2018-09-06 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100000507 |
| 160013453 | 160012244 | 1.67 | 44 | null | 2020-11-04 | 2020-11-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100513473 |
| 160013460 | 160012245 | 1.79 | 92.6 | Palliative (P) | 2017-11-16 | 2017-11-16 | DOCETAXEL + GEMCITABINE | N | N | PACLITAXEL | 100364850 |
| 160013463 | 160012246 | 1.74 | 83.3 | Palliative (P) | 2018-02-11 | 2018-03-03 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101114092 |
| 160013465 | 160012247 | 1.77 | 52.2 | null | 2019-07-07 | 2020-01-02 | Bevacizumab 7.5mg/kg | null | null | DOXORUBICIN + OLARATUMAB | 101503806 |
| 160013467 | 160012248 | 1.77 | 90 | Palliative (P) | 2019-12-28 | 2020-01-20 | CARBOPLATIN | N | N | CARBOPLATIN | 100456432 |
| 160013468 | 160012249 | 1.76 | 81 | Palliative (P) | 2017-06-06 | 2017-06-06 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101301272 |